These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 17189183)

  • 21. Role for Kruppel-like factor 4 in determining the outcome of p53 response to DNA damage.
    Zhou Q; Hong Y; Zhan Q; Shen Y; Liu Z
    Cancer Res; 2009 Nov; 69(21):8284-92. PubMed ID: 19826046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Both p53-PUMA/NOXA-Bax-mitochondrion and p53-p21cip1 pathways are involved in the CDglyTK-mediated tumor cell suppression.
    Yu Z; Wang H; Zhang L; Tang A; Zhai Q; Wen J; Yao L; Li P
    Biochem Biophys Res Commun; 2009 Sep; 386(4):607-11. PubMed ID: 19540190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AP4 encodes a c-MYC-inducible repressor of p21.
    Jung P; Menssen A; Mayr D; Hermeking H
    Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15046-51. PubMed ID: 18818310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Savior and slayer: the two faces of p53.
    Bensaad K; Vousden KH
    Nat Med; 2005 Dec; 11(12):1278-9. PubMed ID: 16333263
    [No Abstract]   [Full Text] [Related]  

  • 25. The dark side of a tumor suppressor: anti-apoptotic p53.
    Jänicke RU; Sohn D; Schulze-Osthoff K
    Cell Death Differ; 2008 Jun; 15(6):959-76. PubMed ID: 18356920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of apoptosis by vinblastine via c-Jun autoamplification and p53-independent down-regulation of p21WAF1/CIP1.
    Kolomeichuk SN; Bene A; Upreti M; Dennis RA; Lyle CS; Rajasekaran M; Chambers TC
    Mol Pharmacol; 2008 Jan; 73(1):128-36. PubMed ID: 18094076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Che-1: a new effector of checkpoints signaling.
    Floridi A; Fanciulli M
    Cell Cycle; 2007 Apr; 6(7):804-6. PubMed ID: 17377493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Che-1 gene silencing induces osteosarcoma cell apoptosis by inhibiting mutant p53 expression.
    Liu M; Wang D; Li N
    Biochem Biophys Res Commun; 2016 Apr; 473(1):168-173. PubMed ID: 27012205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Translational research? Ribosome integrity and a new p53 tumor suppressor checkpoint.
    Opferman JT; Zambetti GP
    Cell Death Differ; 2006 Jun; 13(6):898-901. PubMed ID: 16557265
    [No Abstract]   [Full Text] [Related]  

  • 30. eEF1Bγ binds the Che-1 and TP53 gene promoters and their transcripts.
    Pisani C; Onori A; Gabanella F; Delle Monache F; Borreca A; Ammassari-Teule M; Fanciulli M; Di Certo MG; Passananti C; Corbi N
    J Exp Clin Cancer Res; 2016 Sep; 35(1):146. PubMed ID: 27639846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Che-1 promotes tumor cell survival by sustaining mutant p53 transcription and inhibiting DNA damage response activation.
    Bruno T; Desantis A; Bossi G; Di Agostino S; Sorino C; De Nicola F; Iezzi S; Franchitto A; Benassi B; Galanti S; La Rosa F; Floridi A; Bellacosa A; Passananti C; Blandino G; Fanciulli M
    Cancer Cell; 2010 Aug; 18(2):122-34. PubMed ID: 20708154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIPK2 sustains apoptotic response by phosphorylating Che-1/AATF and promoting its degradation.
    De Nicola F; Catena V; Rinaldo C; Bruno T; Iezzi S; Sorino C; Desantis A; Camerini S; Crescenzi M; Floridi A; Passananti C; Soddu S; Fanciulli M
    Cell Death Dis; 2014 Sep; 5(9):e1414. PubMed ID: 25210797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stabilization of the p53-DNA Complex by the Nuclear Protein Dmp1α.
    Kendig RD; Kai F; Fry EA; Inoue K
    Cancer Invest; 2017 May; 35(5):301-312. PubMed ID: 28406729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53 partners with RNA in the DNA damage response.
    Huarte M
    Nat Genet; 2016 Oct; 48(11):1298-1299. PubMed ID: 27787509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Che-ating death: CHE1/AATF protects from p53-mediated apoptosis.
    Jackson JG; Lozano G
    EMBO J; 2012 Oct; 31(20):3951-3. PubMed ID: 22960635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging roles of AATF: Checkpoint signaling and beyond.
    Srinivas AN; Suresh D; Mirshahi F; Santhekadur PK; Sanyal AJ; Kumar DP
    J Cell Physiol; 2021 May; 236(5):3383-3395. PubMed ID: 33145763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new baby in the c-Myc-directed transcriptional machinery: Che-1/AATF.
    Folgiero V; Sorino C; Locatelli F; Fanciulli M
    Cell Cycle; 2018; 17(11):1286-1290. PubMed ID: 29943642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcription factor target practice.
    Holstege FC; Clevers H
    Cell; 2006 Jan; 124(1):21-3. PubMed ID: 16413477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The anti-apoptotic factor Che-1/AATF links transcriptional regulation, cell cycle control, and DNA damage response.
    Passananti C; Fanciulli M
    Cell Div; 2007 Jul; 2():21. PubMed ID: 17634135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NFIA-ETO2, TP53, and erythroid leukemogenesis.
    Huang BJ; Shannon K
    Blood; 2023 May; 141(18):2168-2170. PubMed ID: 37140954
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.